Daniel Relton

Daniel focuses on a wide range of commercial contracts, particularly within the health care and life sciences, and technology and telecommunication sectors. Within health care and life sciences, Daniel regularly advises pharmaceutical companies on supply chain, distribution, licensing and development agreements. In the technology and telecommunications space, Daniel assists on large technology and business process outsourcing clients for large multinationals. Daniel also regularly works with the Baker McKenzie Transactions Team advising on services agreements arising out of M&A and carve-outs and divestments. Daniel is ranked as a key lawyer in the Legal 500 for life sciences, commercial contracts, and IT and telecoms noting his “high-quality drafting work.” In addition to Daniel’s transactional work, he regularly advises FinTechs, financial instructions and platformers on digital and technology regulations.

Health Care and Life Sciences

• Advising Sandoz on ancillary manufacturing, supply and distribution arrangements resulting from their USD 100 million divestment of Sandoz China to Aspen and the EUR 55.5 million acquisition of commercialisation rights in Europe to certain Aspen aesthetic products.
• Advising Novonesis on supply and distribution matters connected to their EUR 1.5 billion acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance.
• Advising Haleon on the divestment of their ex-US rights to their nicotine replacement therapy brands to Dr. Reddy’s Laboratories.
• Advising GSK on contractual separation matters related to the spinning out of their consumer healthcare division, Haleon.
• Advising a large multinational biopharmaceutical company on the creation of 3PL and 4PL template agreements and updates to their voluntary licensing programme.
• Advising a US biopharmaceutical company on the launch of originator product in the EU, including negotiating with vendors for HTA, EAP and distribution.
• Advising a medical device company on the move from an indirect distribution model to a direct distribution model in the UK and various EU jurisdictions.

Outsourcing, Technology and Telecommunications

• Advising a national bank on technology and business process outsourcing arrangements with a leading Indian informational technology and business services company.
• Advising Colt Technology Services on their USD 1.8 billion acquisition of Lumen's EMEA business.
• Advising Colt Technology Services on their divestment of certain data centres acquired through the Lumen acquisition.
• Advising an MVNE on a dispute and mediation arising from the insolvency of a key MVNO customer.
• Advising a British telecommunications infrastructure company on a full technology outsourcing with an Indian based supplier.

• Society for Computers and Law

Daniel regularly engages in Pro Bono matters for the firm, including projects for Save the Children International, Amnesty, Amicus and CORAM, and was listed on the Pro Bono Recognition List 2025.

Daniel is a member of Baker McKenzie's committees on charity and sustainability.